There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d2896747e50">Gonorrhoea is a major public health concern globally.
Of particularly grave concern
is that resistance to the extended-spectrum cephalosporins has emerged during the
most recent years. This guideline provides recommendations regarding the diagnosis
and treatment of gonorrhoea in Europe. Compared to the outdated 2009 European gonorrhoea
guideline, this 2012 European gonorrhoea guideline provides up-to-date guidance on,
broader indications for testing and treatment of gonorrhoea;the introduction of dual
antimicrobial therapy (ceftriaxone 500 mg and azithromycin 2 g) for uncomplicated
gonorrhoea when the antimicrobial sensitivity is unknown; recommendation of test of
cure in all gonorrhoea cases to ensure eradication of infection and identify emerging
resistance; and recommendations to identify, verify and report failures with recommended
treatment regimens. Optimisations of the testing, diagnostics, antimicrobial treatment
and follow-up of gonorrhoea patients are crucial in controlling the emergent spread
of cephalosporin-resistant and multidrug-resistant gonorrhoea.
</p>